Cargando…

Effect of CETP Polymorphism on Atorvastatin Lipid-Regulating Effect and Clinical Prognosis of Patients with Coronary Heart Disease

BACKGROUND: The aim of this study was to investigate the influence of genetic polymorphism of cholesteryl ester transfer protein (CETP) gene polymorphism −629C/A on the therapeutic effect of atorvastatin and clinical outcome in Han Chinese patients with coronary heart disease (CHD). MATERIAL/METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Guo-Long, Xu, Xiao-Lin, Yang, Qing-You, Zeng, Ruo-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2014
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285921/ https://www.ncbi.nlm.nih.gov/pubmed/25547030 http://dx.doi.org/10.12659/MSM.892711

Ejemplares similares

CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population
por: Wang, Jun, et al.
Publicado: (2013)

Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia
por: Anagnostopoulou, Katherine K, et al.
Publicado: (2009)

Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
por: Xu, Danyan, et al.
Publicado: (2017)

Relationship between CETP gene polymorphisms with coronary artery disease in Polish population
por: Iwanicka, Joanna, et al.
Publicado: (2018)

Effect of atorvastatin therapy on borderline vulnerable lesions in patients with acute coronary syndrome
por: Yu, Dan-Qing, et al.
Publicado: (2011)

A meta-analytic evaluation of cholesteryl ester transfer protein (CETP) C-629A polymorphism in association with coronary heart disease risk and lipid changes
por: Lin, Shouwei, et al.
Publicado: (2016)

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia
por: Peng, You, et al.
Publicado: (2018)

Gender specific effect of CETP rs708272 polymorphism on lipid and atherogenic index of plasma levels but not on the risk of coronary artery disease: A case–control study
por: Cai, Gaojun, et al.
Publicado: (2018)

Vitamin D Levels and Lipid Response to Atorvastatin
por: Pérez-Castrillón, José Luis, et al.
Publicado: (2010)

Association of CETP Gene Polymorphisms and Haplotypes with Cardiovascular Risk
por: Piko, Peter, et al.
Publicado: (2023)

Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP
por: Ølnes, Åsa Schawlann, et al.
Publicado: (2023)

Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
por: Mabuchi, Hiroshi, et al.
Publicado: (2014)

Association of CETP Taq1B and -629C > A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population
por: Lu, Yongjian, et al.
Publicado: (2013)

Association between CETP, MLXIPL, and TOMM40 polymorphisms and serum lipid levels in a Latvian population
por: Radovica, I., et al.
Publicado: (2014)

The impact of common polymorphisms in CETP and ABCA1 genes with the risk of coronary artery disease in Saudi Arabians
por: Cyrus, Cyril, et al.
Publicado: (2016)

Effect of atorvastatin in patients with chronic heart failure – insights from randomized clinical trials
por: Xu, Minwen, et al.
Publicado: (2010)

Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome
por: Vondrakova, Dagmar, et al.
Publicado: (2010)

The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease
por: Wang, Qing, et al.
Publicado: (2016)

Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy
por: Zhang, Qing-Hui, et al.
Publicado: (2018)

Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism
por: Deguchi, Hiroshi, et al.
Publicado: (2016)

CETP Activity: A Link between Lipid Metabolism and Coagulation System
por: Hatakeyama, Kinta
Publicado: (2016)

A Polynesian-specific missense CETP variant alters the lipid profile
por: Moors, Jaye, et al.
Publicado: (2023)

Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease
por: Li, Tao, et al.
Publicado: (2018)

Effects of Atorvastatin in Patients with Acute Spinal Cord Injury
por: Aghazadeh, Javad, et al.
Publicado: (2017)

Inhibition of Rho-kinase is involved in the therapeutic effects of atorvastatin in heart ischemia/reperfusion
por: Cheng, Chao, et al.
Publicado: (2020)

A Nutrigenetic Update on CETP Gene–Diet Interactions on Lipid-Related Outcomes
por: Wuni, Ramatu, et al.
Publicado: (2022)

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction
por: Zhou, Langping, et al.
Publicado: (2023)

CETP/LPL/LIPC gene polymorphisms and susceptibility to age-related macular degeneration
por: Wang, Ya-Feng, et al.
Publicado: (2015)

Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer’s disease
por: Xiao, Zhijie, et al.
Publicado: (2012)

Clinical Characteristics and Prognosis of Young Patients with Coronary Heart Disease
por: Zheng, Ruyi, et al.
Publicado: (2020)

Association between Six CETP Polymorphisms and Metabolic Syndrome in Uyghur Adults from Xinjiang, China
por: Hou, Huixian, et al.
Publicado: (2017)

Changes in Homocysteine Levels Affect Serum Lipid Response to Atorvastatin in Patients With Acute Coronary Syndrome: A Retrospective Observational Study
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Association study between polymorphisms in MIA3, SELE, SMAD3 and CETP genes and coronary artery disease in an Iranian population
por: Rayat, Sima, et al.
Publicado: (2022)

Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy
por: Peng, Shi, et al.
Publicado: (2018)

Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids
por: Zimmermann, Friederike, et al.
Publicado: (2020)

APOE, CETP and LPL genes show strong association with lipid levels in Greek children()
por: Smart, M.C., et al.
Publicado: (2010)

Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease
por: Zhao, Yuhong, et al.
Publicado: (2017)

Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention
por: Lin, Xuefeng, et al.
Publicado: (2013)

Effect of Atorvastatin on Serial Changes in Coronary Physiology and Plaque Parameters
por: Lee, Cheol Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dspdrdc45dihon2pmcas52ur6l